Sapiens International (NASDAQ:SPNS) Price Target Lowered to $30.00 at Barclays

Sapiens International (NASDAQ:SPNSGet Free Report) had its target price lowered by stock analysts at Barclays from $38.00 to $30.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “underweight” rating on the technology company’s stock. Barclays‘s target price suggests a potential upside of 2.28% from the stock’s previous close.

Several other research firms have also weighed in on SPNS. The Goldman Sachs Group upped their price objective on Sapiens International from $38.00 to $43.00 and gave the company a “buy” rating in a research note on Friday, August 2nd. StockNews.com raised Sapiens International from a “buy” rating to a “strong-buy” rating in a research note on Monday. Finally, Needham & Company LLC dropped their price objective on Sapiens International from $44.00 to $35.00 and set a “buy” rating for the company in a research note on Tuesday.

Get Our Latest Report on SPNS

Sapiens International Stock Performance

Sapiens International stock traded up $0.23 on Tuesday, hitting $29.33. The company’s stock had a trading volume of 105,847 shares, compared to its average volume of 127,071. The company has a fifty day moving average price of $36.34 and a 200-day moving average price of $35.45. The firm has a market cap of $1.63 billion, a P/E ratio of 23.99 and a beta of 1.25. Sapiens International has a one year low of $24.91 and a one year high of $41.22. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.04.

Institutional Trading of Sapiens International

Large investors have recently made changes to their positions in the business. Morgan Dempsey Capital Management LLC raised its position in shares of Sapiens International by 9.5% during the second quarter. Morgan Dempsey Capital Management LLC now owns 4,206 shares of the technology company’s stock worth $143,000 after acquiring an additional 365 shares during the last quarter. Foyston Gordon & Payne Inc raised its holdings in Sapiens International by 8.2% during the 2nd quarter. Foyston Gordon & Payne Inc now owns 7,317 shares of the technology company’s stock worth $248,000 after purchasing an additional 556 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in Sapiens International by 5.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,328 shares of the technology company’s stock valued at $384,000 after purchasing an additional 569 shares during the period. Financial Management Professionals Inc. boosted its stake in shares of Sapiens International by 57.9% in the 3rd quarter. Financial Management Professionals Inc. now owns 1,945 shares of the technology company’s stock valued at $72,000 after purchasing an additional 713 shares during the last quarter. Finally, Summit Securities Group LLC acquired a new stake in shares of Sapiens International during the 2nd quarter worth approximately $34,000. Institutional investors own 30.73% of the company’s stock.

About Sapiens International

(Get Free Report)

Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.

See Also

Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.